Status:
COMPLETED
Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal Infections
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Abdominal Abscess
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The primary objective of this study is to compare the safety and efficacy of an experimental antibiotic to a marketed antibiotic in the treatment of Chinese subjects with complicated intra-abdominal i...
Eligibility Criteria
Inclusion
- · Hospitalized male or female subjects over 18 years of age
Exclusion
- · Subjects with any concomitant condition that, in the opinion of the investigator, would preclude an evaluation of a response or make it unlikely that the contemplated course of therapy or follow-up visits could be completed.
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
End Date :
December 1 2006
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00136201
Start Date
November 1 2005
End Date
December 1 2006
Last Update
July 7 2009
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Guoxuexiang, Chengdu, China, 610041
2
Shengyang, Liaoning, China, 110001
3
Hangzhou, Zhejiang, China
4
Beijing, China, 100044